186 related articles for article (PubMed ID: 24069370)
1. Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival.
Guo C; Lu H; Gao W; Wang L; Lu K; Wu S; Pataer A; Huang M; El-Zein R; Lin T; Roth JA; Mehran R; Hofstetter W; Swisher SG; Wu X; Fang B
PLoS One; 2013; 8(9):e74973. PubMed ID: 24069370
[TBL] [Abstract][Full Text] [Related]
2. Preoperative serum levels of insulin-like growth factor-binding protein 2 predict prognosis of gastric cancer patients.
Hur H; Yu EJ; Ham IH; Jin HJ; Lee D
Oncotarget; 2017 Feb; 8(7):10994-11003. PubMed ID: 28036255
[TBL] [Abstract][Full Text] [Related]
3. Serum IGFBP2 Level Is a New Candidate Biomarker of Severe Malnutrition in Advanced Lung Cancer.
Dong J; Zeng Y; Zhang P; Li C; Chen Y; Li Y; Wang K
Nutr Cancer; 2020; 72(5):858-863. PubMed ID: 32286106
[No Abstract] [Full Text] [Related]
4. Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival.
Yang J; Griffiths M; Nies MK; Brandal S; Damico R; Vaidya D; Tao X; Simpson CE; Kolb TM; Mathai SC; Pauciulo MW; Nichols WC; Ivy DD; Austin ED; Hassoun PM; Everett AD
BMC Med; 2020 Oct; 18(1):268. PubMed ID: 33019943
[TBL] [Abstract][Full Text] [Related]
5. Preoperative plasma IGFBP2 is associated with nodal metastasis in patients with penile squamous cell carcinoma.
Hu X; Chen M; Liu W; Li Y; Fu J
Urol Oncol; 2019 Jul; 37(7):452-461. PubMed ID: 31053522
[TBL] [Abstract][Full Text] [Related]
6. Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy.
Tang D; Yao R; Zhao D; Zhou L; Wu Y; Yang Y; Sun Y; Lu L; Gao W
Sci Rep; 2018 Mar; 8(1):3917. PubMed ID: 29500455
[TBL] [Abstract][Full Text] [Related]
7. Is insulin-like growth factor binding protein 2 associated with metastasis in lung cancer?
Hu Q; Huang L; Kuang X; Zhang H; Ling G; Chen X; Li K; Deng Z; Zhou J
Clin Exp Metastasis; 2014 Jun; 31(5):535-41. PubMed ID: 24682597
[TBL] [Abstract][Full Text] [Related]
8. Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma.
Patel D; Ellis R; Howard B; Boufraqech M; Gara SK; Zhang L; Quezado MM; Nilubol N; Kebebew E
Ann Surg Oncol; 2014 Oct; 21(11):3541-7. PubMed ID: 24833102
[TBL] [Abstract][Full Text] [Related]
9. Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer.
Kendrick ZW; Firpo MA; Repko RC; Scaife CL; Adler DG; Boucher KM; Mulvihill SJ
HPB (Oxford); 2014 Jul; 16(7):670-6. PubMed ID: 24308545
[TBL] [Abstract][Full Text] [Related]
10. Cardiorenal interaction and heart failure outcomes. A role for insulin-like growth factor binding protein 2?
Ravassa S; Beaumont J; Cediel G; Lupón J; López B; Querejeta R; Díez J; Bayés-Genís A; González A
Rev Esp Cardiol (Engl Ed); 2020 Oct; 73(10):835-843. PubMed ID: 31948893
[TBL] [Abstract][Full Text] [Related]
11. Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival.
Griffiths M; Yang J; Nies M; Vaidya D; Brandal S; Williams M; Matsui EC; Grant T; Damico R; Ivy D; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Rosenzweig EB; Hirsch R; Yung D; Everett AD
Pediatr Res; 2020 Dec; 88(6):850-856. PubMed ID: 32927467
[TBL] [Abstract][Full Text] [Related]
12. Circulating IGF system and treatment outcome in epithelial ovarian cancer.
Huang YF; Cheng WF; Wu YP; Cheng YM; Hsu KF; Chou CY
Endocr Relat Cancer; 2014 Apr; 21(2):217-29. PubMed ID: 24273235
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of serum insulin-like growth factor-binding protein 2 for ovarian cancer.
Prayudi PKA; Budiana ING; Mahayasa PD; Surya IGNHW; Wiradnyana AAGP; Suwiyoga K
Int J Gynecol Cancer; 2020 Nov; 30(11):1762-1767. PubMed ID: 32817171
[TBL] [Abstract][Full Text] [Related]
14. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
15. Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.
Dong J; Yu J; Li Z; Gao S; Wang H; Yang S; Wu L; Lan C; Zhao T; Gao C; Liu Z; Wang X; Hao J
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):704-716. PubMed ID: 33763996
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against insulin-like growth factor‑binding protein-2 as a serological biomarker in the diagnosis of lung cancer.
Zhang Y; Ying X; Han S; Wang J; Zhou X; Bai E; Zhang J; Zhu Q
Int J Oncol; 2013 Jan; 42(1):93-100. PubMed ID: 23165420
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of IGFBP2 mRNA predicts poor survival in patients with glioblastoma.
Yuan Q; Cai HQ; Zhong Y; Zhang MJ; Cheng ZJ; Hao JJ; Wang MR; Wan JH
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138764
[TBL] [Abstract][Full Text] [Related]
18. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like Growth Factor Binding Protein 2 predicts mortality risk in heart failure.
Barutaut M; Fournier P; Peacock WF; Evaristi MF; Caubère C; Turkieh A; Desmoulin F; Eurlings LWM; van Wijk S; Rocca HB; Butler J; Koukoui F; Dambrin C; Mazeres S; Le Page S; Delmas C; Galinier M; Jung C; Smih F; Rouet P
Int J Cardiol; 2020 Feb; 300():245-251. PubMed ID: 31806281
[TBL] [Abstract][Full Text] [Related]
20. Physiological Disturbance in Fatty Liver Energy Metabolism Converges on IGFBP2 Abundance and Regulation in Mice and Men.
Fahlbusch P; Knebel B; Hörbelt T; Barbosa DM; Nikolic A; Jacob S; Al-Hasani H; Van de Velde F; Van Nieuwenhove Y; Müller-Wieland D; Lapauw B; Ouwens DM; Kotzka J
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
